bronchitis

ResApp raises $9.74M for respiratory disease diagnostic app

By Aditi Pai 03:50 pm April 20, 2016

Australia-based ResApp, a public company, has raised $9.74 million ($12.5 million Australian dollars) for its product, a smartphone-based system for diagnosing respiratory conditions. The company sold 62.5 million new ordinary shares at $0.16 ($0.20 AU) per share. ResApp’s offering essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But instead of...

Study: Smartphone app that listens to breathing, determines respiratory diseases is 89 percent accurate

By Jonah Comstock 12:44 pm April 4, 2016

A smartphone-based system for diagnosing respiratory diseases achieved an accuracy of 89 percent in a recent clinical study of 524 pediatric patients conducted by the company at Joondalup Health Campus (JHC) and Princess Margaret Hospital (PMH) in Perth, Western Australia. Perth-based ResApp essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But...